
    
      A total of 70 patients with HCC (mean age: 54.6 years, female/male: 12/58) received a liver
      transplant and were included in the study. Immunosuppression included de novo sirolimus,
      low-dose calcineurin inhibitor for 6 to 12 months, with short-course (3 months) or no
      steroids.
    
  